サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：鼠径ヘルニア器具の世界市場-2023年～2030年
市場調査レポート
商品コード
1374795

鼠径ヘルニア器具の世界市場-2023年～2030年

Global Inguinal Hernia Devices Market -2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
鼠径ヘルニア器具の世界市場-2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

鼠径ヘルニア治療器具は、ヘルニア周囲の傷ついた組織の治癒を促進するために使用される医療器具です。これらの器具は鼠径ヘルニア修復術（ヘルニアの膨らみを元の位置に押し戻し、腹壁の弱さを補強する外科手術）に使用されます。鼠径ヘルニア治療器具は通常メッシュで構成され、ヘルニアの周囲を縫ったり、ホッチキスで留めたり、接着したりします。

メッシュには孔が開いており、組織が器具の中に成長するため、ヘルニアの再発や再燃の可能性を減らすことができます。鼠径ヘルニア修復手術では、メッシュの他に縫合糸（ステッチ）、時にはメッシュが使用されることもあります。

ヘルニアを修復する手術は開腹手術と腹腔鏡手術があり、外科医は患者さんにとってどのタイプの麻酔が最適かを判断します。全体として、鼠径ヘルニア器具は鼠径ヘルニアの外科治療の重要な要素であり、損傷した組織を支え、ヘルニアの再発を防ぐのに役立ちます。

市場力学：市場促進要因と市場抑制要因

鼠径ヘルニア手術件数の増加

鼠径ヘルニアの修復件数の増加は、鼠径ヘルニア器具市場の主要促進要因です。例えば、米国外科学会（American College of Surgeons）の2023年版報告書によると、鼠径ヘルニア修復術は米国だけで年間100万件行われており、世界の推定ではこのような手術は毎年2,000万件を超えていることから、ヘルニア修復術は世界的に最も頻繁に行われる一般外科手術の一つとなっています。

さらに、本報告書は鼠径ヘルニアの発生が増加していることを強調し、ヘルニア修復の選択肢に対する大きな需要を示しています。このような需要の急増は、医療機器メーカーが革新的な製品を開発する必要性を示しています。例えば、腹部の3次元（3D）画像化により、医師は従来の開腹手術のような大きな切開ではなく、小さな切開で手術を行うことができるようになり、患者の組織損傷が少なく、痛みが少なく、術後の回復が早くなり、ヘルニア修復術を成功させるための高まるニーズを満たすことができるようになっています。

市場力学：市場抑制要因

ヘルニア器具に関連する高コストと規制機関がもたらす課題は潜在的な障壁となり、予測期間中の世界の鼠径ヘルニア器具市場に大きな影響を与える可能性があります。これらの器具の高コストは、低開発地域における治療へのアクセスを制限し、ヘルスケア施設に負担をかけ、手術を選択することになる患者の意思決定に影響を与える可能性があります。

規制当局の厳しい承認プロセスやコンプライアンス・コストは、市場への参入や製品開発を目指す企業にとって障害となる可能性があります。持続的な痛み、感染症、ヘルニアの再発、癒着、腸閉塞、メッシュ関連の問題などの合併症は、不満につながり、追加の医療介入が必要になる可能性があります。これはヘルスケアコストに影響するだけでなく、ヘルニア修復手術を受けることを躊躇する人もいます。これらの課題を克服することは、業界の利害関係者にとって、市場の成長を促進するために極めて重要です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 鼠径ヘルニア手術件数の増加
    • 抑制要因
      • ヘルニア器具に関連する高コストと規制当局による課題。
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 タイプ別

  • 間接鼠径ヘルニア
  • 直接鼠径ヘルニア
  • 両側鼠径ヘルニア
  • 大腿ヘルニア

第8章 製品別

  • ヘルニアメッシュ
  • ヘルニア固定器具
  • ヘルニア修復消耗品

第9章 年齢層別

  • 小児
  • 成人

第10章 手術方法別

  • 開腹手術
  • 腹腔鏡手術
  • ロボット支援ヘルニア手術
  • ノンメッシュ手術

第11章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Olympus Corporation
    • 会社概要
    • 製品タイプのポートフォリオと説明
    • 財務概要
    • 主な発展
  • Johnson & Johnson
  • Sinolinks Medical Innovation, Inc.
  • Beijing Biosis Healing Biological Technology Co.,Ltd
  • Betatech Medical
  • Medtronic
  • W. L. Gore & Associates, Inc.
  • Dynamesh Inc.
  • Cousin Biotech
  • Cook Medical

第15章 付録

目次
Product Code: MD7311

Overview

Inguinal hernia devices are medical devices that are used to promote the healing of injured tissue around hernias. These devices are used in inguinal hernia repair, a surgical procedure that presses a hernia bulge back into position and reinforces the abdominal wall weakness. Inguinal hernia devices usually consist of mesh and are stitched, stapled, or glued across the area surrounding the hernia.

Pores in the mesh allow tissue to grow into the device, which reduces the chance of a hernia recurring or relapsing. In addition to mesh devices, sutures (stitches) and sometimes mesh may be utilized during inguinal hernia repair surgery.

The surgery to repair the hernia can be open or laparoscopic, and the surgeon will determine which type of anesthesia is best for the patient. Overall, inguinal hernia devices are a key component of the surgical treatment of inguinal hernias, and they can help to support damaged tissue and prevent the hernia from returning.

Market Dynamics: Drivers and Restraints

The increasing number of inguinal hernia repairs

The rising number of inguinal hernia repairs is a major driver of the inguinal hernia device market. For instance, according to the American College of Surgeons 2023 report, 1 million inguinal hernia repairs are performed annually in the U.S. alone and a global estimate exceeding 20 million such surgeries each year, hernia repair has become one of the most often performed general surgical procedures globally.

Furthermore, this report emphasizes the increasing occurrence of inguinal hernias, indicating a huge demand for hernia repair options. This spike in demand indicates the need for medical device manufacturers to develop innovative products such as three-dimensional (3D) imaging of the abdomen allowed doctors to perform surgery through small incisions rather than the huge incisions linked with traditional open surgery, leading to less tissue damage, less pain, and faster postoperative recovery for patients and thereby fulfilling the rising need for successful hernia repair procedures.

Market Dynamics: Restraint

The high cost associated with hernia devices and the challenges posed by regulatory bodies can be a potential barrier and have a significant impact on the global inguinal hernia device market over the forecast period. The high cost of these devices may limit access to treatment in under developed regions and put strain on healthcare facility and influence patients decision making when it comes to opting for surgery.

The strict regulatory approval processes and compliance costs can create obstacles for companies looking to enter the market or develop products. Complications such as persistent pain, infections, hernia recurrence, adhesions, bowel obstructions, mesh-related issuesand others can lead to dissatisfaction and necessitate additional medical interventions. This not affects healthcare costs but also discourages some individuals from undergoing hernia repair surgery. Overcoming these challenges is crucial for industry stakeholders in order to foster growth, in the market.

Segment Analysis

The global inguinal hernia device market is segmented based on type, product, age group, surgical procedure, end user and region.

The hernia mesh segment accounted for approximately 44.2 % of the market share

The hernia mesh segment accounted for 44.2% and it is expected to be dominated during the forecast period. The segment holds a position, in the market due to its usage and effectiveness in inguinal hernia repair procedures. These meshes offer support to weakened abdominal walls reducing the chances of hernia recurrence. They are available in materials and designs catering to the needs of patients. Additionally, rise of minimal invasive procedures has led to popularity due increasing number of surgeries has led to a higher demand, for hernia meshes as they work well with these procedures.

The increasing funding for the development of advanced mesh will create a positive impact on the market. For instance, in August 2022, Deep Blue Medical Advances, a Durham company previously funded with more than $400,000 in North Carolina Biotechnology Center loans, has raised more than $7 million in venture capital to facilitate development with the commercialization of its T-Line Hernia Mesh product. This innovative device intends to eliminate a common source of failure in conventional mesh fixation, reinforce anchors, and improve hernia repair procedures.

Furthermore, in February 2022, Dolphin Mesh, manufactured in India by Futura Surgicare Pvt Ltd, launched a premium surgical mesh brand built for "tension-free" and laparoscopic hernia repairs. These meshes serve as crucial devices in surgeries that strengthens weakened areas, enable tissue ingrowth, and may be modified to meet individual surgical demands. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of hernia, product approvals and FDA clearance, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, in October 2022, Medtronic plc, a prominent global healthcare technology business, received approvals for its Hugo robotic-assisted surgery (RAS) system, expanding its market reach and indications globally. Particulary, Health Canada has received a license for general laparoscopic surgery use. These approvals bring up new options for minimally invasive surgery in Europe, North America, and Asia, making the benefits more accessible globally. These treatments range from simple to sophisticated and include cholecystectomy, inguinal hernia repair, gastric bypass, and lower anterior resection.

Furthermore, in June 2023, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, received the U.S. FDA approval for the Pre-Market Approval (PMA) of LiquiBandFix8 for use in hernia surgery. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. Thus, owing to the above factors the region is expected to dominate over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has majorly impacted the market, as it has resulted in a significant decrease in the amount of elective hernia repairs, particularly incisional hernia surgery. For instance, according to British Journal of Surgery 2022 article, inguinal hernia is a common surgical disease in children, with a 6% to 16% frequency in preterm and low-birthweight infants. The COVID-19 pandemic impacted hospital services, but it also presented a unique opportunity to collect clinical outcomes for children with inguinal hernia who would face delays in operative therapy, including the chance of spontaneous resolution while awaiting operative repair.

During the COVID-19 pandemic, twenty-five UK pediatric surgical centers took part in observational research evaluating the therapy of inguinal hernia in infants under 6 months of age. The study discovered a substantial decrease in the frequency of inguinal hernia repairs performed during the pandemic compared to the same period in the previous year.

Competitive Landscape

The major global players in the inguinal hernia devices market include: B Braun Melsungen AG, Johnson & Johnson, Sinolinks Medical Innovation, Inc., Beijing Biosis Healing Biological Technology Co.,Ltd, Betatech Medical, Medtronic, W. L. Gore & Associates, Inc., Dynamesh Inc., Cousin Biotech, Cook Medical and among others.

Why Purchase the Report?

  • To visualize the global inguinal hernia devices market segmentation-based on type, product, age group, surgical procedure, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of inguinal hernia devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global inguinal hernia devices market report would provide approximately 79 tables, 79 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by Surgical Procedure
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. The increasing number of inguinal hernia repairs
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost associated with hernia devices and the challenges posed by regulatory bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Indirect Inguinal Hernia*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Direct Inguinal Hernia
  • 7.4. Bilateral Inguinal Hernia
  • 7.5. Femoral Hernia

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Hernia Meshes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hernia Fixation Devices
  • 8.4. Hernia Repair Consumables

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Pediatric*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Adult

10. By Surgical Procedure

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 10.1.2. Market Attractiveness Index, By Surgical Procedure
  • 10.2. Open Surgery*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Laparoscopic Surgery
  • 10.4. Robotic-assisted Hernia Repair
  • 10.5. Non-mesh Procedures

11. By End-users

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 11.1.2. Market Attractiveness Index, By End-users
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Specialty Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Olympus Corporation*
    • 14.1.1. Company Overview
    • 14.1.2. Product Type Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Johnson & Johnson
  • 14.3. Sinolinks Medical Innovation, Inc.
  • 14.4. Beijing Biosis Healing Biological Technology Co.,Ltd
  • 14.5. Betatech Medical
  • 14.6. Medtronic
  • 14.7. W. L. Gore & Associates, Inc.
  • 14.8. Dynamesh Inc.
  • 14.9. Cousin Biotech
  • 14.10. Cook Medical

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us